Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.20 -0.30 (-1.46%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Gross Margin (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Gross Margin of 42.01% for Q2 2026, up 2.50 percentage points from 39.51% a year earlier but down 2.29 percentage points from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Gross Margin (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at Amneal Pharmaceuticals was 39.32%, up 1.65 percentage points year-over-year; for FY2025, it was 36.88%, up 0.36 percentage points from FY2024.

  • Annual Gross Margin shows a five-year change of +5.34 percentage points (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Gross Margin was 36.52% in FY2024 (+2.24 pp), 34.28% in FY2023 (-1.19 pp), 35.47% in FY2022 (-1.26 pp) and 36.73% in FY2021 (+5.19 pp).
  • Quarterly Gross Margin has run from a low of 30.77% in Q4 2023 to a high of 44.31% in Q1 2026 over five years.
  • On a year-over-year basis, Gross Margin has increased in each of the last three quarters, with an average year-over-year change of +2.22 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q3 2021, with a gain of 11.83 percentage points; the weakest was Q4 2023, with a drop of 4.56 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 44.31% (Q1 2026), 36.50% (Q4 2025) and 34.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Amneal Pharmaceuticals 6.55 Bn 5.82 Bn 334.51 Mn 42.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.01%
Mar 31, 2026 44.31%
Dec 31, 2025 36.50%
Sep 30, 2025 34.92%
Jun 30, 2025 39.51%
Mar 31, 2025 36.80%
Dec 31, 2024 35.98%
Sep 30, 2024 38.37%
Jun 30, 2024 35.62%
Mar 31, 2024 36.11%
Dec 31, 2023 30.77%
Sep 30, 2023 37.50%
Jun 30, 2023 36.73%
Mar 31, 2023 31.96%
Dec 31, 2022 35.32%
Sep 30, 2022 35.60%
Jun 30, 2022 35.85%
Mar 31, 2022 35.08%
Dec 31, 2021 30.99%
Sep 30, 2021 37.55%
API Access

Amneal Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=AMRX&period=max&api_key=YOUR_API_KEY